A JAMA Pediatrics study of 1,012 hospitalized infants found maternal RSV vaccine effectiveness to be 77.8% against lung infection admissions through six months.
Australian Data Put the Maternal RSV Vaccine at 78 Percent Effective Against Infant Lung Infection Admissions
by | Aug 21, 2026 | Uncategorized | 0 comments
Recent Comments